3-64686885-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_182920.2(ADAMTS9):​c.199G>T​(p.Val67Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000274 in 1,614,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

ADAMTS9
NM_182920.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.774
Variant links:
Genes affected
ADAMTS9 (HGNC:13202): (ADAM metallopeptidase with thrombospondin type 1 motif 9) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
ADAMTS9-AS2 (HGNC:42435): (ADAMTS9 antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14429012).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADAMTS9NM_182920.2 linkc.199G>T p.Val67Phe missense_variant 2/40 ENST00000498707.5 NP_891550.1 Q9P2N4-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADAMTS9ENST00000498707.5 linkc.199G>T p.Val67Phe missense_variant 2/401 NM_182920.2 ENSP00000418735.1 Q9P2N4-3

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152138
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000875
AC:
22
AN:
251476
Hom.:
0
AF XY:
0.0000662
AC XY:
9
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000193
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000282
AC:
412
AN:
1461892
Hom.:
0
Cov.:
32
AF XY:
0.000259
AC XY:
188
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000343
Gnomad4 OTH exome
AF:
0.000497
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152256
Hom.:
0
Cov.:
33
AF XY:
0.000202
AC XY:
15
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000412
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000327
Hom.:
0
Bravo
AF:
0.000174
ExAC
AF:
0.0000824
AC:
10
EpiCase
AF:
0.000545
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 03, 2022The c.199G>T (p.V67F) alteration is located in exon 2 (coding exon 2) of the ADAMTS9 gene. This alteration results from a G to T substitution at nucleotide position 199, causing the valine (V) at amino acid position 67 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;.;.
Eigen
Benign
0.0052
Eigen_PC
Benign
-0.00079
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.35
T;T;T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.14
T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Uncertain
2.7
M;M;.
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.56
N;N;N
REVEL
Benign
0.16
Sift
Benign
0.71
T;T;T
Sift4G
Benign
0.71
T;T;T
Polyphen
0.81
P;.;.
Vest4
0.32
MutPred
0.40
Loss of MoRF binding (P = 0.0813);Loss of MoRF binding (P = 0.0813);Loss of MoRF binding (P = 0.0813);
MVP
0.71
MPC
0.68
ClinPred
0.48
T
GERP RS
1.5
Varity_R
0.14
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs753622011; hg19: chr3-64672561; COSMIC: COSV55775480; COSMIC: COSV55775480; API